Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Whole Transcriptome RNA Sequencing As a Comprehensive Diagnostic Tool for Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 2762.

https://doi.org/10.1182/blood-2018-99-111115

Published: 2018

Journal Articles

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

Marieke Griffioen, PhD, Wibowo Arindrarto, MSc, Daniel Borràs, MSc, Saskia A.M.E. van Diessen, BSc, Edith D. van der Meijden, M. Willy Honders, Mariam Alloul, PhD, Inge Jedema, PhD, Wilma G.M. Kroes, PhD, Peter J.M. Valk, PhD, Bart Janssen, PhD, Cornelis A.M. van Bergen, PhD, Szymon M. Kiełbasa, PhD, Jeroen F.J. Laros, PhD, Peter A.C. 't Hoen, PhD, Hendrik Veelken, MD PhD

Blood (2016) 128 (22): 1701.

https://doi.org/10.1182/blood.V128.22.1701.1701

Published: 2016

Journal Articles

Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO

Anita N. Kremer, Edith D. van der Meijden, Maria W. Honders, Jelle J. Goeman, Emmanuel J. H. J. Wiertz, J. H. Frederik Falkenburg, Marieke Griffioen

Blood (2012) 120 (16): 3246–3255.

https://doi.org/10.1182/blood-2011-12-399311

Published: 2012

Includes: Supplemental data

Journal Articles

High Throughput Screening for Antibody Responses Against H-Y Antigens and Their X-Variants in Allogeneic Hematopoeietic Stem Cell Transplantation,

Judith C van der Griendt, MSc, Edith D van der Meijden, Burcu Ayoglu, Jochen M Schwenk, Peter Nilsson, J.H. Frederik Falkenburg, MD, PhD, Marieke Griffioen, PhD

Blood (2011) 118 (21): 4097.

https://doi.org/10.1182/blood.V118.21.4097.4097

Published: 2011

Journal Articles

Primary Antibody Responses Against the Novel Pandemic H1N1 and Secondary Antibody Responses Against Seasonal H1N1 Can Be Induced by Vaccination In Patients Early After Allogeneic Stem Cell Transplantation

Roselke E Klinkenberg, MD, Marieke Griffioen, PhD, Edith D van der Meijden, Erik W.A. Marijt, MD, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2010) 116 (21): 1273.

https://doi.org/10.1182/blood.V116.21.1273.1273

Published: 2010

Journal Articles

Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro

Caroline E. Rutten, Simone A. P. van Luxemburg-Heijs, Edith D. van der Meijden, Marieke Griffioen, Machteld Oudshoorn, Roel Willemze, J. H. Frederik Falkenburg

Blood (2010) 115 (1): 151–153.

https://doi.org/10.1182/blood-2009-10-249821

Published: 2010

Journal Articles

High Throughput Minor Histocompatibility Antigen Discovery by Whole Genome Association Scanning.

Cornelis A.M. van Bergen, Edith D. van der Meijden, Caroline E. Rutten, Simone A.P. van Luxemburg, Elisabeth G.A. Lurvink, M. Willy Honders, Jeanine J. Houwing, M. Lourdes Sampietro, Roelof Willemze, J.H. Frederik Falkenburg, Marieke Griffioen

Blood (2009) 114 (22): 685.

https://doi.org/10.1182/blood.V114.22.685.685

Published: 2009

Journal Articles

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

Marieke Griffioen, M. Willy Honders, Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Elisabeth G.A. Lurvink, Roel Willemze, J.H. Frederik Falkenburg

Blood (2009) 114 (22): 4084.

https://doi.org/10.1182/blood.V114.22.4084.4084

Published: 2009

Journal Articles

Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity

Anita N. Stumpf, Edith D. van der Meijden, Cornelis A. M. van Bergen, Roel Willemze, J. H. Frederik Falkenburg, Marieke Griffioen

Blood (2009) 114 (17): 3684–3692.

https://doi.org/10.1182/blood-2009-03-208017

Published: 2009

Journal Articles

Identification of Four New HLA Class II Restricted Minor Histocompatibility Antigens Contributing to Graft Versus Leukemia Reactivity.

Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Marieke Griffioen, PhD

Blood (2008) 112 (11): 3247.

https://doi.org/10.1182/blood.V112.11.3247.3247

Published: 2008

Journal Articles

Detailed Analysis of CD8+ T Cell Immunity and Identification of a Novel Minor Histocompatibility Antigen Contributing to Graft-Versus- Leukemia Reactivity.

Marieke Griffioen, PhD, M. Willy Honders, Edith D. van der Meijden, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2008) 112 (11): 3250.

https://doi.org/10.1182/blood.V112.11.3250.3250

Published: 2008

Journal Articles

HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1 Specific T Cell Responses Showing Immunogenicity of All HLA-DPB1 Alleles

Caroline E. Rutten, M.D., Simone A.P. van Luxemburg-Heijs, Edith D. van der Meijden, Marieke Griffioen, PhD, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD

Blood (2008) 112 (11): 3504.

https://doi.org/10.1182/blood.V112.11.3504.3504

Published: 2008

Journal Articles

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Marieke Griffioen, Edith D. van der Meijden, M. Willy Honders, Caroline Rutten, Simone A.P. van Luxemburg-Heijs, Peter A. von dem Borne, Roelof Willemze, J.H. Frederik Falkenburg

Blood (2007) 110 (11): 1800.

https://doi.org/10.1182/blood.V110.11.1800.1800

Published: 2007

Journal Articles

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, J. H. Frederik Falkenburg

Blood (2006) 107 (12): 4954–4960.

https://doi.org/10.1182/blood-2005-09-3883

Published: 2006

Journal Articles

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Elisabeth H. Slager, PhD, M. Willy Honders, Edith D. van der Meijden, Simone A.P. van Luxemburg-Heijs, Freke M. Kloosterboer, PhD, Michel G.D. Kester, Inge Jedema, PhD, W.A. Erik Marijt, PhD, MD, M. Ronald Schaafsma, PhD, MD, J.H. Frederik Falkenburg, PhD, MD, Roel Willemze, PhD, MD

Blood (2005) 106 (11): 3094.

https://doi.org/10.1182/blood.V106.11.3094.3094

Published: 2005

NARROW

Whole Transcriptome RNA Sequencing As a Comprehensive Diagnostic Tool for Acute Myeloid Leukemia

Whole Transcriptome Sequencing (RNAseq) As a Comprehensive, Cost-Efficient Diagnostic Tool for Acute Myeloid Leukemia

Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO

High Throughput Screening for Antibody Responses Against H-Y Antigens and Their X-Variants in Allogeneic Hematopoeietic Stem Cell Transplantation,

Primary Antibody Responses Against the Novel Pandemic H1N1 and Secondary Antibody Responses Against Seasonal H1N1 Can Be Induced by Vaccination In Patients Early After Allogeneic Stem Cell Transplantation

Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro

High Throughput Minor Histocompatibility Antigen Discovery by Whole Genome Association Scanning.

Diversity of HLA Class I and Class II Restricted Minor Histocompatibility Antigens in Graft-Versus-Leukemia Reactivity.

Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity

Identification of Four New HLA Class II Restricted Minor Histocompatibility Antigens Contributing to Graft Versus Leukemia Reactivity.

Detailed Analysis of CD8+ T Cell Immunity and Identification of a Novel Minor Histocompatibility Antigen Contributing to Graft-Versus- Leukemia Reactivity.

HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1 Specific T Cell Responses Showing Immunogenicity of All HLA-DPB1 Alleles

Identification of Phosphatidylinositol 4-Kinase Type II β as the First HLA Class II Associated Minor Histocompatibility Antigen Involved in Graft Versus Leukemia Reactivity.

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only